Knowledge Community Insider


Former Ford plant turned cancer science and research hub, The Assembly opens in Bloomfield

What was once a former production plant and showroom floor for Ford Motor Co. and its Model T in Bloomfield is now — more than 100 years later — the home to what officials hope will serve as an epicenter of innovation in life sciences for university researchers, entrepreneurs and other companies that work in related fields.

Executives with the University of Pittsburgh and Baltimore, Maryland-based developer Wexford Science & Technology LLC, among others, celebrated the official opening on Thursday of The Assembly, a 355,000-square-foot facility that includes floors of laboratories, research & development areas and office space in addition to an auditorium that can hold 250 people and a parking garage with 324 spaces.

Pittsburgh Business Times  |  May 5, 2022 (Subscription needed)

Read More

Additional Article:
Pitt opens a cutting-edge biomedical research hub at The Assembly  (PittWire  |  May 10, 2022)

Q&A: Real estate’s fast-emerging frontier in cancer care and R&D

Thomas Osha has a unique vantage point when it comes to innovation districts rooted in the life sciences. As executive vice president of Wexford Technology + Science out of Baltimore, he runs point for one of the most active U.S. developers of real estate used by major research universities and their private-sector partners. He recently caught up with Ashley Fahey, The Business Journals’ national real estate editor, to talk about post-pandemic development and how demand is reshaping real estate needs in the realm of cancer-related R&D and treatment. Below is an edited transcript of their conversation.

Read More

 The Business Journals   |  June 16, 2022  (Subscription needed) 

How Atrium Health’s partnership with ‘super magnet’ IRCAD will bolster innovation district in Charlotte


Charlotte-based Atrium announced IRCAD as an anchor partner for The Pearl innovation district earlier this year. The institute offers world-class research and training for surgeons, specializing in minimally invasive techniques and robotics-driven tools for diagnosis and simulation. It has six training centers in five countries, including Taiwan, Brazil and Rwanda, and trains more than 7,200 physicians each year. The local center will be its North American base.

Charlotte Business Journal   |   June 20, 2022 (Subscription needed)

Read More

UW Regents’ Recent Approval of 11-Story Development Marks the Latest Chapter for University of Washington

The University of Washington, founded in 1861 approximately a decade after the founding of Seattle, is one of the oldest universities on the West Coast. Despite its storied history, the University has no intention to rest on its laurels and it continues to break new ground to expand its reach throughout the Emerald City as another recent development – one of several over the last several years – takes shape.

In mid-March, the University of Washington Board of Regents, which supervises, coordinates, manages, and regulates the university, approved the development plan for the first major project in the UW’s newly named Portage Bay Crossing area, which is on the west side of the Seattle campus.

According to a statement released by the University, Wexford Science + Technology LLC will develop and manage an 11-story building totaling about 340,000 rentable square feet of lab, office, collaboration and retail space. The UW’s Clean Energy Institute, Brotman Baty Institute and Institute for Protein Design are also slated to occupy a significant amount of the space.

The Registry  |   May 12, 2022

Read More

If you’re looking for a life sciences job, here’s good evidence you should look in Philly

Philly ranks No. 8 on the new Life Sciences Talent Report, which identifies the top 25 life sciences labor markets after assessing the largest 74 markets in the United States. Of note, the region has the third-highest number of biochemists and biophysicists of any US metro, falling just behind the Boston-Cambridge region and New York-New Jersey region.

Technical.ly  |   June 16, 2022

Read More

Integral Molecular doubling its space and headcount in Philadelphia through $10M expansion project


One of the Philadelphia region’s oldest biotechnology companies is doubling its footprint, and its workforce, in the city.

Integral Molecular began construction this week on its new 50,000-square scientific and operational headquarters at One uCity Square that will allow the company to expand to 200 employees over the next few years.

Founded in 2001, Integral Molecular currently has about 100 employees. It last expanded in the University City section of Philadelphia in 2019 when it opened a 26,000-square-foot research site at 3624 Market St.

“We have experienced extraordinary growth while operating under pandemic conditions and are proud of the business challenges that we have overcome,” said Benjamin Doranz, Integral Molecular’s co-founder and CEO. “Despite uncertain times, we have launched technologies that have been instrumental in the fight against Covid-19 and discovered antibodies to combat intractable cancers.”

Philadelphia Business Journal  |  May 26, 2022  (Subscription needed)

Read More

Spirovant Launches State-of-the-Art Laboratory and Headquarters

Spirovant Sciences, a gene therapy company developing treatments for respiratory diseases, including cystic fibrosis (CF), announced today the launch of its new state-of-the-art research laboratory and corporate headquarters in Philadelphia. The new research facilities will allow the company to accelerate development of its lead program targeting CF, support the vector manufacturing process, and build capabilities to grow its platform and pipeline into therapeutic opportunities.

Press Release  |  May 16, 2022

Read More

A strategic relocation to Baltimore supports one biomedical company’s growth


KaloCyte cofounders Dr. Allan Doctor and Dr. Dipanjan Pan were slated to relocate to Maryland and launch the Center for Blood Oxygen Transport & Hemostasis at the University of Maryland School of Medicine nearly three years ago.

But instead of being forced to choose between leaving behind their biotech startup and forming CBOTH, they made the best of both worlds right in the heart of Baltimore: The St. Louis-founded startup moved into CBOTH as a University of Maryland BioPark affiliate in July 2019.

The BioPark, located on the University of Maryland, Baltimore’s campus, is home to nearly three dozen life sciences companies. Tenants range from early-stage companies to major global firms like BD, Catalent, Illumina, and Pharmaron. Its prime location in Maryland’s biomedical ecosystem made it an ideal new home for KaloCyte, which is developing a critically-needed red blood cell substitute for use when perishable donor blood is not available or in short supply.

“We chose UMB and the BioPark for two main reasons: to have the company co-located with our academic founders to continue our research, and also because of the tremendous resources that the university and region offers that simply were not available in St. Louis,” KaloCyte President and CEO Elaine Haynes said.

Technical.ly |  June 9, 2022

Read More

Cell Engineering startup Vita Therapeutics moves to UM BioPark


Maryland Inno  |  May 9, 2022
(Subscription needed)

Read More

Life Science Development Projects Position Baltimore BioMed Ecosystem for Boom


BioBuzz  |  April 5, 2022


Read More

Philly is movin’ up in the top 30 list for global startup ecosystems


Technical.ly  |  June 14, 2022


Read More